CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


<
Alexion Pharmaceuticals Inc  (ALXN)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Alexion Pharmaceuticals Inc

ALXN's Financial Statements and Analysis






Alexion Pharmaceuticals Inc reported in I. Quarter net earnings per share of $1.11 an increase by 48 % year on year from $0.75 and an improvement of 753.85 % from $0.13 realized in IV. Quarter (Dec 31 2017).

Alexion Pharmaceuticals Inc's Revenue rose by % in I. Quarter (Mar 31 2018) year on year, to $931 million and advanced by 2.33 % sequentially.


Alexion Pharmaceuticals Inc is Expected to report next financial results on July 23, 2018.
More on ALXN's Income Statement

I. Quarter
Earnings Per Share Revenues
$ 1.11 $  931 Mill
$+0.36     +48 % $+61M     +7 %
You need to upgrade your Flash Player
ALXN's NET INCOME

Alexion Pharmaceuticals Inc's net income of $249 million in I. Quarter increased by 46.53 % from net earnings of $170 million achieved in I. Quarter a year ago.

Sequentially net earnings grew by 722.11 % from net income of $30.30 million realized in previous quarter.

More on ALXN's Growth

Inventories Inventories grew by 15.28 % to $457 million from I. Quarter a year ago, sequentially inventories fell by -0.85 %. In I. Quarter company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -11.20%, to $-67 millions compare to same quarter a year ago and rose by -24.58% from IV. Quarter (Dec 31 2017).

More on ALXN's Cash flow Statement



Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 4.95 cash per share, on a free-cash flow basis 213.28 % of net earning per share.

Book value grew by 3.34 % sequentially to $40.74 per share, 66.83% of net income per share in trailing twelve-month period were contributed to shareholder value.


Company repurchased 1.90 million shares or 0.84 % in I. Quarter.
Interest Coverage Ratio was 8.16. Debt Coverage Ratio was 0.28.

More on ALXN's Dividends
 Market Capitalization (Millions) 30,235
 Shares Outstanding (Millions) 224
 Total Debt (Millions $) 2,846
 Revenue (TTM) (Millions $) 3,612
 Net Income (TTM) (Millions $) 522
 Cash Flow (TTM) (Millions $) -129
 Capital Exp. (TTM) (Millions $) -349
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273





Alexion Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals Inc earned $ 4.95 cash per share, on a free-cash flow basis 213.28 % of net earning per share.

Book value grew by 3.34 % sequentially to $40.74 per share, 66.83% of net income per share in trailing twelve-month period were contributed to shareholder value.


Company repurchased 1.90 million shares or 0.84 % in I. Quarter.
Interest Coverage Ratio was 8.16. Debt Coverage Ratio was 0.28.

More on ALXN's Dividends
 Market Capitalization (Millions) 30,235
 Shares Outstanding (Millions) 224
 Total Debt (Millions $) 2,846
 Revenue (TTM) (Millions $) 3,612
 Net Income (TTM) (Millions $) 522
 Cash Flow (TTM) (Millions $) -129
 Capital Exp. (TTM) (Millions $) -349
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OCC's Profile

Stock Price

OCC's Financials

Business Description

Fundamentals

Charts & Quotes

OCC's News

Suppliers

OCC's Competitors

Customers & Markets

Economic Indicators

OCC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071